Patent ID: 11913052
Assignee: NORTHWESTERN UNIVERSITY
Field: Biotechnology (Chemistry)
Classification: CPC C  Y | IPC C

Claim 7:
8. The method of claim 1, wherein:
a) when the target peptide is valinomycin or intermediates or derivatives thereof, the NRPS is one or more of Vlm1 and Vlm2;
b) when the target peptide is andrimid or intermediates or derivatives thereof, the NRPS is one or more of AdmA, AdmB, AdmC, AdmD, AdmE, AdmF, AdmG, AdmH, AdmI, AdmJ, AdmK, AdmL, AdmM, AdmN, AdmO, AdmP, AdmQ, AdmR, AdmS, AdmT, AdmU;
c) when the target peptide is enterobactin or intermediates or derivatives thereof, the NRPS is one or more of EntA, EntB, EntC, EntD, EntE, EntF;
d) when the target peptide is styrene or intermediates or derivatives thereof, the NRPS is one or more of Pal22 and FDC1;
e) when the target peptide is Gramicidin S or intermediates or derivatives thereof, the NRPS is one or more of GrsA and GrsB;
f) when the target peptide is limonene or intermediates or derivatives thereof, the NRPS is one or more of ACAT, HMGS, HMGR, MK, PMK, PMDIDI, GPPS, and LS;
g) when the target peptide is pinene or intermediates or derivatives thereof, the NRPS is ACAT, HMGS, HMGR, MK, PMK, PMDIDI, GPPS, and PS;
h) when the target peptide is bisabolene or intermediates or derivatives thereof, the NRPS is ACAT, HMGS, HMGR, MK, PMK, PMDIDI, GPPS, FPP; or
i) when the target peptide is 3-hydroxybutyrate or intermediates or derivatives thereof, the NRPS is Th1, Hbd, Crt and Ter.